Cardia to research diabetes links
23 July, 2002 by Melissa TrudingerCardia Technologies has signed an option agreement worth $10,000 on diabetes type 1 food toxin research at the International Diabetes Institute (IDI).
New ResMed devices win US approval
22 July, 2002 by Melissa TrudingerMeditech company ResMed's latest sleep apnoea devices, the S7 Elite CPAP and AutoSet Spirit autotitrating devices, have been approved by the FDA for sale in the USA.
New CSIRO spin-off to develop drugs from bugs
22 July, 2002 by Tanya HollisThink twice before you next swat an insect - it could end up saving your life. A collaboration of leading research organisations has formed a private company to screen an insect library for potentially therapeutic molecules.
pSivida technology in new drug delivery trial
22 July, 2002 by Iain ScottA new deal will see an unnamed UK biopharma using nanotechnology developed by Perth biotech pSivida in vaccine delivery trials.
Norwood joins with US company to market anaesthetic
22 July, 2002 by Tanya HollisLaser drug delivery group Norwood Abbey has finalised an agreement with United States drug company Ferndale Laboratories over the joint marketing of an anaesthetic product.
NZ govt seeks more advice on GM liability
19 July, 2002 by Melissa TrudingerThe New Zealand government will seek further advice to supplement the Law Commission's report on liability issues for GMOs, which was released this week.
Scientists comment on proposed GM moratorium in South Australia
19 July, 2002 by Melissa TrudingerLeading South Australian agricultural scientists are alarmed by a proposed Bill by South Australian Democrat Ian Gilfillan to place a five-year moratorium on GMOs in South Australia.
Australian Animal Health Laboratory director appointed
18 July, 2002 by Melissa TrudingerCSIRO has appointed Dr Martyn Jeggo, international expert on livestock disease detection and control, as the new director of the Australian Animal Health Laboratory in Geelong.
New Burnet head to research edible vaccine research
18 July, 2002 by Tanya HollisAn edible vaccine project is among the research programs to be introduced by incoming Burnet Institute director Prof Steven Wesselingh.
CSL subsidiary strikes agreement with Novartis
18 July, 2002 by Tanya HollisCSL's Swiss subsidiary has struck a deal with drug company Novartis over the marketing and distribution of its intravenous immunoglobulin product.
Ambri appoints business development manager
18 July, 2002 by Tanya HollisBiosensor developer Ambri has appointed a new business development manager to drive sales of its SensiDx System throughout the Asia Pacific region.
Brisbane start-up Protagonist aims for more of a leading role
18 July, 2002 by Pete YoungDrug design start-up Protagonist is attempting to move up the food chain from a tools-oriented company to one with a proprietary interest in the molecules it designs and synthesises.
New Australian group in kidney bioengineering push
17 July, 2002 by Tanya HollisA consortium of Australia's top kidney scientists has come together with the ambitious goal of using stem cells to engineer a bioartificial organ.
New director for Ventracor
17 July, 2002 by Tanya HollisArtificial heart device developer Ventracor has appointed a new director to its ranks.
Peptech looks towards positive second half result in shareholder address
16 July, 2002 by Tanya HollisSydney company Peptech is hinging its hopes for a positive second half result on the issuing of US patents for its anti tumour nectrotising factor.
